9 results found.

Brain and Central Nervous System Tumors, Cognitive/Functional Eff Clinical Trial using modafinil; placebo

University of South Florida - Recruiting 6 years to 17 years.
- A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor.
modafinil; placebo

Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Ne Clinical Trial using questionnaire administration; cognitive assessment; psychosocial assessment and care; quality-of-life assessment

Children's Oncology Group - Recruiting 1 Month to 21 years.
- Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer.
questionnaire administration; cognitive assessment; psychosocial assessment and care; quality-of-life assessment

B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Function Clinical Trial using cognitive assessment; psychosocial assessment and care; diffusion tensor imaging; laboratory biomarker analysis; pharmacological study

Children's Oncology Group - Recruiting 1 year to 17 years.
- A Study of Neurocognitive Function in Children Treated for ALL.
cognitive assessment; psychosocial assessment and care; diffusion tensor imaging; laboratory biomarker analysis; pharmacological study

Side Effects of Calcineurin Inhibitors, Renal Toxicity, Hepatic F Clinical Trial using Liver biopsy

Thomas Jefferson University - Recruiting 18 years or older.
- Sirolimus Switching From Calcinurin Inhibitors (CNI) 90 - 180 Days After Liver Transplantation.
Liver biopsy

Male Breast Cancer, Neurotoxicity, Peripheral Neuropathy, Stage I Clinical Trial using laboratory biomarker analysis; questionnaire administration

Fox Chase Cancer Center - Recruiting 18 years or older.
- Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy.
laboratory biomarker analysis; questionnaire administration

Non-small Cell Lung Cancer Clinical Trial using Monosialoganglioside(GM1); normal saline

Sun Yat-sen University - Recruiting N/A or older.
- A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial of Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by First-line Chemotherapy Contained Cisplatin in Non-small Cell Lung Cancer Patients..
Monosialoganglioside(GM1); normal saline

Chemotherapeutic Agent Toxicity, Lymphoma, Mucositis, or Neurotox Clinical Trial using glucarpidase; leucovorin calcium; methotrexate; laboratory biomarker analysis; quality-of-life assessment; radiation therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients With Primary Central Nervous Lymphoma (PCNSL).
glucarpidase; leucovorin calcium; methotrexate; laboratory biomarker analysis; quality-of-life assessment; radiation therapy

Breast Cancer Clinical Trial using Paclitaxel 80 mg/m2; Nab-paclitaxel 100 mg/m2 days 1, 8 and 15; Nab-paclitaxel 150 mg/m2 days 1, 8 and 15; Nab-paclitaxel 150 mg/m2 days 1 and 15

Asociaci¢n Oncosur - Recruiting 18 years or older.
- Neurotoxicity Characterization Phase II Randomized Study of Nab-paclitaxel Versus Conventional Paclitaxel as First-line Therapy of Metastatic HER2-negative Breast Cancer..
Paclitaxel 80 mg/m2; Nab-paclitaxel 100 mg/m2 days 1, 8 and 15; Nab-paclitaxel 150 mg/m2 days 1, 8 and 15; Nab-paclitaxel 150 mg/m2 days 1 and 15

Neurotoxicity Clinical Trial using Vitamin D3

West Virginia University - Recruiting 18 years to 90 years.
- Phase II Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through the Vitamin D Pathway.
Vitamin D3